Key Points
- CEO Jack Bendheim has sold roughly 101,600 shares of PAHC between Nov. 4 and Dec. 9, generating about $4.52 million in proceeds (including a 3,520-share sale on Dec. 8 at $40.06), and now directly owns 46,240 shares valued at ~ $1.85M.
- Phibro recently beat quarterly estimates with $0.73 EPS on $363.9M revenue, set FY2026 guidance of 2.64–2.81 EPS, and announced a quarterly dividend of $0.12 (annualized yield ~1.2%).
Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 1,288 shares of the business's stock in a transaction dated Tuesday, December 9th. The shares were sold at an average price of $40.19, for a total value of $51,764.72. Following the completion of the transaction, the chief executive officer owned 44,952 shares in the company, valued at $1,806,620.88. This trade represents a 2.79% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Jack Bendheim also recently made the following trade(s):
- On Monday, December 8th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.06, for a total value of $141,011.20.
- On Wednesday, December 3rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.77, for a total value of $143,510.40.
- On Tuesday, November 25th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.93, for a total transaction of $309,267.20.
- On Wednesday, November 26th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The shares were sold at an average price of $44.02, for a total transaction of $232,425.60.
- On Monday, November 17th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.56, for a total value of $235,276.80.
- On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The shares were sold at an average price of $44.47, for a total transaction of $391,380.47.
- On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.23, for a total value of $974,073.28.
- On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.29, for a total transaction of $1,734,742.87.
- On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $42.86, for a total transaction of $150,867.20.
- On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total value of $151,712.00.
Phibro Animal Health Trading Up 3.3%
NASDAQ:PAHC traded up $1.33 during mid-day trading on Thursday, reaching $41.20. The company's stock had a trading volume of 32,229 shares, compared to its average volume of 279,352. The company has a debt-to-equity ratio of 2.32, a current ratio of 3.09 and a quick ratio of 1.35. The stock has a market cap of $1.67 billion, a P/E ratio of 24.78, a P/E/G ratio of 1.08 and a beta of 0.77. The company's fifty day simple moving average is $41.16 and its two-hundred day simple moving average is $34.35. Phibro Animal Health Corporation has a twelve month low of $16.16 and a twelve month high of $46.42.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.58 by $0.15. Phibro Animal Health had a net margin of 4.85% and a return on equity of 36.26%. The company had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, equities analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current year.
Phibro Animal Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Wednesday, November 26th. Phibro Animal Health's dividend payout ratio (DPR) is 28.92%.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on PAHC. Bank of America lifted their price objective on Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a research note on Friday, August 29th. Zacks Research upgraded shares of Phibro Animal Health from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. Weiss Ratings reissued a "buy (b-)" rating on shares of Phibro Animal Health in a research note on Monday. Morgan Stanley set a $34.00 price target on shares of Phibro Animal Health in a research report on Thursday, August 28th. Finally, JPMorgan Chase & Co. increased their target price on Phibro Animal Health from $45.00 to $50.00 and gave the company an "overweight" rating in a research note on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $31.40.
View Our Latest Stock Analysis on Phibro Animal Health
Institutional Investors Weigh In On Phibro Animal Health
Hedge funds and other institutional investors have recently bought and sold shares of the business. Tudor Investment Corp ET AL boosted its stake in shares of Phibro Animal Health by 3.4% during the 3rd quarter. Tudor Investment Corp ET AL now owns 10,184 shares of the company's stock valued at $412,000 after buying an additional 338 shares during the last quarter. Danske Bank A S bought a new stake in shares of Phibro Animal Health in the third quarter worth $955,000. Advisory Services Network LLC acquired a new stake in Phibro Animal Health in the third quarter valued at $96,000. Dark Forest Capital Management LP bought a new position in Phibro Animal Health during the 3rd quarter valued at $2,751,000. Finally, Virtus Advisers LLC grew its holdings in Phibro Animal Health by 922.9% during the 3rd quarter. Virtus Advisers LLC now owns 48,576 shares of the company's stock worth $1,965,000 after acquiring an additional 43,827 shares in the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.
Phibro Animal Health Company Profile
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
